Skip to content

Novanta NOVT Price / sales

Price / sales at other companies

Stryker logo
StrykerSYK
-1.1×
Coherent logo
CoherentCOHR
6.8×+5.0×
Intuitive Surgical logo
Intuitive SurgicalISRG
15.5×-4.9×
Onto Innovation logo
Onto InnovationONTO
9.9×+4.1×
Nordson logo
NordsonNDSN
5.5×+1.6×
Globus Medical logo
Globus MedicalGMED
3.8×-0.3×

Other financials

Income statement

See full
Revenue$257.7M+10.4%
Gross profit$113.6M+8.8%
Operating income$27.5M-15.1%
Net income$21.1M-0.5%
EPS (diluted)$0.51-13.6%

Balance sheet

See full
Cash & equivalents$388.8M+267%
Total debt$291.3M-34.2%
Total equity$1.3B+70.3%
Total assets$1.8B+29.9%

Cash flow

See full
Operating cash flow$51.6M+62.9%
CapEx$4.1M-3.4%
Free cash flow$47.5M+73.2%

Valuation

See full
Market cap$5.53B-8.3%

Profitability

See full
Gross margin44.2%-0.5pp
Operating margin8.9%-3.5pp
Net margin5.3%-2.1pp
FCF margin6.8%-8.1pp

Returns & leverage

See full
Return on equity5.2%-4.6pp
Debt / equity0.2×-0.4×
Current ratio3.6×+1.0×

Where this comes from

Calculated from Novanta’s reported figures.

Based on the most recent quarter.

The official record: Novanta’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novanta's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Novanta's price / sales?
Novanta (NOVT) reported price / sales of 4.2× in Q1 2026.
How has Novanta's price / sales changed year-over-year?
Novanta's price / sales decreased by 13.2% year-over-year, from 4.8× to 4.2×.
What is the long-term trend for Novanta's price / sales?
Over 5 years (2020 to 2025), Novanta's price / sales has grown at a -9.3% compound annual growth rate (CAGR), from 7.1× to 4.3×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.